Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine

Psychiatry Research

Volumn 188, Issue 3, 2011, Pages 315-319

  Werneck, Ana Paula ^a   Hallak, Jaime Cecilio ^a   Nakano, Eduardo ^b   Elkis, Helio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Amisulpride; Clozapine; Depot antipsychotics; Olanzapine; Oral antipsychotics; Outcome; Risperidone

Indexed keywords

AMISULPRIDE; CLOZAPINE; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; TREATMENT INDICATION;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBSERVATION; PATIENT DISCHARGE; PATIENT READMISSION; RETROSPECTIVE STUDIES; RISPERIDONE; SCHIZOPHRENIA; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 79960700035     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.04.004     Document Type: Article

References (20)

1. Burns T. Evolution of outcome measures in schizophrenia. The British Journal of Psychiatry 2007, 191:1-6.
2. Burns T. Hospitalisation as an outcome measure in schizophrenia. The British Journal of Psychiatry 2007, 191:37-41.
3. Castro A., Elkis H. Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine. Revista Brasileira de Psiquiatria 2007, 29:207-212.
4. Conley R., Kelly D., Love R., McMahon R.P. Rehospitalization risk with second-generation and depot antipsychotics. Annals of Clinical Psychiatry 2003, 15:23-31.
5. Conley R.R., Love R.C., Kelly D.L., Bartko J.J. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine. The American Journal of Psychiatry 1999, 156:863-868.
6. Elkis H. Treatment-resistant schizophrenia. The Psychiatric Clinics of North America 2007, 30:511-533.
7. Essock S., Hargreaves W., Covell N., Goethe J. Clozapine's effectiveness for patients in state hospitals: results from a randomized trial. Psychopharmacology Bulletin 1996, 32:683-697.
8. Grimes D., Schulz K. An overview of clinical research: the lay of the land. Lancet 2002, 359:57-61.
9. Henna J., Elkis H. Clinical aspects of super-refractory schizophrenia: a 6-month cohort observational study. Revista Brasileira de Psiquiatria 2007, 29:228-232.
10. Herceg M., Jukic V., Vidovic D., Erdeljic V., Celic I., Kozumplik O., Bagaric D., Radic M.S. Two-year rehospitalization rates of patients with newly diagnosed or chronic schizophrenia on atypical or typical antipsychotic drugs retrospective cohort study. Croatian Medical Journal 2008, 49:215-223.
11. Hotopf M., Churchill R., Lewis G. Pragmatic randomized controlled trials in psychiatry. The British Journal of Psychiatry 1999, 175:217-223.
12. Leucht S., Kissling W., Davis J.M. Second-generation antipsychotics for schizophrenia: can we resolve the conflict?. Psychological Medicine 2009, 39:1591-1602.
13. Lewis S., Barnes T., Davies L., Murray R.M., Dunn G., Hayhurst K.P., Markwick A., Lloyd H., Jones P.B. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophrenia Bulletin 2006, 32:715-723.
14. Lieberman J., Stroup T., McEvoy J., Swartz M., Rosenheck R., Perkins D., Keefe R., Davis S., Davis C., Lebowitz B., Severe J., Hsiao J. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine 2005, 353(12):1209-1223.
15. Lin C.H., Lin S.C., Chen M.C., Wang S.Y. Comparison of time to rehospitalization among schizophrenic patients discharged on typical antipsychotics, clozapine or risperidone. Journal China Medical Association 2006, 69:264-269.
16. McEvoy J., Lieberman J., Stroup T., Davis S.M., Meltzer H.Y., Rosenheck R.A., Swartz M.S., Perkins D.O., Keefe R.S.E., Davis C.E., Severe J., Hsiao J.H. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. The American Journal of Psychiatry 2006, 163:611-622.
17. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Archives of General Psychiatry 1991, 48:764-770.
18. Meltzer H., Rabinowitz J., Lee M., Cola P.A., Ranjan R., Findling R.L., Thompson P.A. Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. The American Journal of Psychiatry 1997, 154:475-482.
19. Patel N.C., Dorson P.G., Edwards N., Mendelson S., Crismon M.L. One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics. Psychiatric Service 2002, 53:891-893.
20. Rabinowitz J., Lichtenberg P., Kaplan Z., Mark M., Nahon D., Davidson M. Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics. The American Journal of Psychiatry 2001, 158:266-269.